RP
ACH

Rowlandmiller & Partners’s Accendra Health ACH Stock Holding History

Rowlandmiller & Partners’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-64,331
Closed -$208K – 139
2019
Q2 		$208K Sell
64,331
-28,825
-31% -$98.3K 0.07% 111
2019
Q1 		$382K Sell
93,156
-8,575
-8% -$54.2K 0.14% 89
2018
Q4 		$644K Sell
101,731
-9,111
-8% -$94.6K 0.26% 67
2018
Q3 		$1.83M Buy
110,842
+424
+0.4% +$7.21K 0.66% 47
2018
Q2 		$1.85M Buy
110,418
+1,945
+2% +$31.5K 0.72% 46
2018
Q1 		$1.69M Buy
108,473
+54,102
+100% +$965K 0.67% 45
2017
Q4 		$1.04M Buy
54,371
+8,893
+20% +$197K 0.41% 51
2017
Q3 		$1.33M Buy
45,478
+8,726
+24% +$258K 0.55% 48
2017
Q2 		$1.18M Buy
36,752
+23,002
+167% +$755K 0.5% 53
2017
Q1 		$475K Buy
+13,750
New +$491K 0.21% 69

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rowlandmiller & Partners's ACH Position: Q3 2019 in Review

Rowlandmiller & Partners sold out of Accendra Health (ACH) in Q3 2019, closing a stake of 64,331 shares — an estimated $208K sold.

Rowlandmiller & Partners first reported a position in ACH in Q1 2017 and held it in 10 quarters. The position peaked at $1.85M in Q2 2018. 175 funds tracked by Wall St. Rank hold ACH as of Q3 2019.

  • Rowlandmiller & Partners reported no remaining Accendra Health position as of Q3 2019 after selling out during the quarter.
  • Rowlandmiller & Partners sold 64,331 Accendra Health shares in Q3 2019, an estimated $208K.
  • Rowlandmiller & Partners first reported a position in Accendra Health in Q1 2017 and held it in 10 quarters.
  • Rowlandmiller & Partners's Accendra Health position peaked at $1.85M in Q2 2018.
  • 175 funds tracked by Wall St. Rank held Accendra Health as of Q3 2019.

Based on Rowlandmiller & Partners's 13F filing for Q3 2019, filed 2 Oct 2019.